Details for New Drug Application (NDA): 022134

✉ Email this page to a colleague

NDA 022134 describes LASTACAFT, which is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge. Additional details are available on the LASTACAFT profile page.

The generic ingredient in LASTACAFT is alcaftadine. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the alcaftadine profile page.

Summary for 022134

Tradename:	LASTACAFT
Applicant:	Abbvie
Ingredient:	alcaftadine
Patents:	2

Pharmacology for NDA: 022134

Mechanism of Action	Histamine H1 Receptor Antagonists

Suppliers and Packaging for NDA: 022134

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
LASTACAFT	alcaftadine	SOLUTION/DROPS;OPHTHALMIC	022134	NDA	Allergan, Inc.	0023-4290	0023-4290-01	1 BOTTLE, PLASTIC in 1 CARTON (0023-4290-01) / 1 mL in 1 BOTTLE, PLASTIC
LASTACAFT	alcaftadine	SOLUTION/DROPS;OPHTHALMIC	022134	NDA	Allergan, Inc.	0023-4291	0023-4291-01	1 BOTTLE, PLASTIC in 1 CARTON (0023-4291-01) / 1 mL in 1 BOTTLE, PLASTIC

Profile for product number 001

Active Rx/OTC/Discontinued:	OTC	Dosage:	SOLUTION/DROPS;OPHTHALMIC			Strength	0.25%
Approval Date:	Jul 28, 2010	TE:		RLD:	Yes
Patent:	10,617,695	Patent Expiration:	Mar 19, 2027	Product Flag?	Y	Substance Flag?		Delist Request?
Patented Use:	USE OF LASTACAFT TO TEMPORARY RELIEVE ITCHY EYES DUE TO POLLEN, RAGWEED, GRASS, ANIMAL HAIR AND DANDER
Patent:	8,664,215	Patent Expiration:	Dec 23, 2027	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	USE OF LASTACAFT TO TEMPORARY RELIEVE ITCHY EYES DUE TO POLLEN, RAGWEED, GRASS, ANIMAL HAIR AND DANDER

Expired US Patents for NDA 022134

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	LASTACAFT	alcaftadine	SOLUTION/DROPS;OPHTHALMIC	022134-001	Jul 28, 2010	5,468,743	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.